Abstract
Introduction: Benign nodular goiter may be associated with swallowing difficulties, but insight into the associated pathophysiology is limited. The aim of this study was to investigate the effect of surgery on the degree of esophageal compression, and its correlation to swallowing difficulties. Methods: Esophageal compression and deviation were evaluated blindly on magnetic resonance imaging (MRI) of the neck, prior to and 6 months after thyroid surgery for symptomatic benign goiter. Goiter symptoms and swallowing difficulties were measured by the Goiter Symptom Scale of the Thyroid-Specific Patient-Reported Outcome (ThyPRO) questionnaire. Cohen’s d was used for evaluating effect sizes (ES). Results: Sixty-four patients completed the study. Before surgery, median goiter volume was 57 (range 14–642) mL. The smallest cross-sectional area of the esophagus (SCAE) increased from a median of 95 (47–147) to 137 (72–286) mm<sup>2</sup> (ES = 1.31, p < 0.001). Median esophagus width increased from 15 (range 10–21) to 17 (range 12–24) mm (ES = 0.94, p < 0.001) after surgery, while no statistically significant change was observed for the sagittal dimension (anterior-to-posterior), thus reflecting an increasingly ellipsoid esophageal shape. Median esophageal deviation decreased moderately after surgery from 4 (0–23) to 3 (0–10) mm (ES = 0.54, p = 0.005). The goiter symptom score improved considerably from (mean ± SD) 40 ± 21 to 10 ± 10 points (ES = 1.5, p < 0.001) after surgery, and the improvements were associated with improvements in SCAE (p = 0.03). Conclusions: In patients with goiter, thyroidectomy leads to substantial improvements in esophageal anatomy, as assessed by MRI, and this correlates with improved swallowing symptoms. This information is valuable in qualifying the dialogue with goiter patients, before deciding on the mode of therapy. Clinicaltrials.gov (NCT03072654).
Introduction
Thyroid glands with nodular degeneration are common and, depending on definition and type of imaging, affect 20–76% of patients on a background of delicate interactions between genetic and environmental factors [1-4]. Nodular goiter can lead to a wide range of symptoms including swallowing discomfort and respiratory disturbances, which can have a negative impact on quality of life (QoL) [1, 5, 6]. A clear correlation between goiter volume, tracheal compression, and relief from this compression following thyroidectomy is seen in patients with benign goiter [7], but little is known concerning the impact of goiter on the esophagus. In studies using patient-reported outcomes, 47–83% of patients referred for thyroidectomy report swallowing difficulties [8-14]. Uncomplicated thyroidectomy significantly improves both symptoms related to swallowing and QoL [5, 9, 15-18], but insights into the pathophysiology of this improvement are limited. Previous studies have found no significant correlations between disturbances in esophageal motility and size and symptoms of goiter, indicating that other measures than motility disturbances might be relevant for goiter symptoms at baseline and the pronounced relief after surgery [10, 19-21].
Esophageal compression and esophageal deviation on radiographic images are reported in 8–27% of patients with goiter [22, 23], and the ill-defined globus sensation seems to be linked to tracheo-esophageal deviation [24]. However, there is no clear definition of either esophageal compression or esophageal deviation, which impedes any attempt at interpreting alterations in these parameters following therapy.
The aim of this study was to investigate the degree of esophageal compression before and after thyroid surgery, and to correlate these findings with changes in goiter symptoms.
Materials and Methods
Participants
Patients with symptomatic benign nodular goiter scheduled for thyroid surgery were included in a prospective cohort study [7, 19]. The inclusion period was from 1 November 2014 to 30 April 2016. Patients were followed for 6 months, with the last visit on 2 March 2017.
Nodular goiter was defined as an ultrasonically confirmed, enlarged thyroid gland, with a volume of > 18 mL for women and > 25 mL for men, and containing at least 1 nodule [7]. Serum levels of total thyroxine (T4) and total tri-iodothyronine (T3) had to be within the normal range of 67–134 and 1.35–2.33 nmol/L, respectively, but both subclinical hypo- and hyperthyroid patients (serum thyrotropin > or < the reference range, respectively) were eligible for inclusion.
Exclusion criteria were: previous neck surgery, a suspected thyroid malignancy (such patients were managed by a fast track program [25]), an age < 20 or > 80 years, neuromuscular diseases including diabetes mellitus, and an inadequate understanding of Danish. This study is a substudy of a larger cohort study investigating changes in tracheal anatomy, swallowing physiology, and QoL after thyroid surgery [7, 16, 19, 26, 27]. In part, the data have been reanalyzed, for the purpose of addressing a completely different issue.
MRI and Esophageal Anatomy
Magnetic resonance imaging (MRI) of the neck was performed using an Achieva D-stream (Phillips, Eindhoven, The Netherlands) operating at 1.5 tesla, using a repetition time of 680 ms, an echo time of 12 ms, and a slice thickness of 7 mm. Scans were performed at a median of 13 (range 1–90) days before and 180 (148–210) days after surgery. To assess esophageal compression, the smallest cross-sectional area of the esophagus (SCAE) was assessed from esophageal cross-sectional areas at the level of the thyroid gland before surgery and from the corresponding level following surgery.
To reflect the shape and surroundings of the esophagus, the anterior-to-posterior (AP) depth and medial-to-lateral (ML) width of the esophagus were measured. Esophageal deviation was measured as the distance from the esophageal center to the midline. In addition, contact between the circumference of the esophagus (in degrees) and closely related structures (within 2 mm) was measured as esophageal contact to the spine, trachea, and thyroid lobes.
Prior to the study, 10 random MRI scans were analyzed twice (by F.A.B.) as part of a training program. The observer performed all measurements using a computer-generated randomization algorithm for blinding. Two to six weeks after the initial examinations, a second evaluation of each patient was performed to allow for intraobserver variation analyses.
Patient Reported Outcomes
Goiter symptoms were evaluated by means of the thoroughly validated Thyroid-Specific Patient-Reported Outcome (ThyPRO) questionnaire [28-32]. Single scales of the ThyPRO measure can be used for measuring specific areas of interest [31]. We selected the 11-item Goiter Symptom Scale which has previously been found to reflect symptoms of swallowing difficulties well [19]. Each item was rated on a Likert scale of 0 (no symptoms) to 4 (severe symptoms), referring to the last 4 weeks. The combined scores of the items were linearly transformed to a scale of 0–100 points, with lower scores meaning fewer symptoms. The questionnaire was completed after the first consultation, and at follow-up 6 months after surgery, without supervision from health care professionals.
Surgical Procedure
A thyroid lobectomy or a total thyroidectomy was performed under general anesthesia by a consultant in head and neck surgery. Patients were discharged on the first postoperative day after a thyroid lobectomy if no clinical or biochemical complications had been encountered. On the first day after a total thyroidectomy, levothyroxine (LT4) was administered and calcium levels were monitored, followed by discharge if these levels were normal. Postsurgical follow-up was scheduled for 2–4 weeks after surgery, and a follow-up with the focus on thyroid hormone levels 2–3 months after surgery. Thereafter, further LT4 adjustment was made by the local department of endocrinology or the patient’s general practitioner.
Statistics
Mean values were calculated from the first and the second measurements, to be used for statistical analyses. A paired t test was used to compare pre- and postsurgical values of esophageal compression, esophageal deviation, and goiter symptoms. Effect sizes (ES) were calculated by Cohen’s d as mean change divided by the standard deviation at baseline. Accordingly, ES were defined as 0.2–0.5 being a small change, 0.5–0.8 a moderate change, and > 0.8 a large change [33].
To estimate the relationship between esophageal parameters at baseline and swallowing difficulties, multiple regression analyses were used for the independent variables: age, sex, and weight of removed thyroid tissue. Multiple regression analyses were also used to compare changes in symptom scores with changes in SCAE, ML width, and esophageal contact to the trachea, spine, and thyroid. A linear mixed model was used to evaluate the influence of gender, age, and intraobserver differences on the esophageal parameters. Bland-Altman plots were used to illustrate intraobserver differences.
Results
Patient Characteristics
A total of 229 patients were initially assessed for eligibility (Fig. 1), 90 of whom were excluded based on predefined exclusion criteria. Sixty-four declined to participate, 5 were unable to complete the examination, and 6 were lost to follow-up, resulting in a total of 64 patients completing all analyses. Eighty-five percent of included patients were females, and the median age was 52 (range 21–77) years, compared to 55 (19–92) years for the patients who were not included (p = 0.76) (Table 1). The median weight of surgically removed thyroid tissue for the included patients was 40 (7–607) g.
Surgical and demographic characteristics of patients with benign symptomatic goiter (n = 64)
MRI and Esophageal Anatomy
The reproducibility in identifying the most affected esophageal level was within 3 mm on MRI scans (0.5 slice thickness, p = 0.007). The AP depth of the esophagus did not change significantly (p = 0.70) following surgery, while the ML width of the esophagus showed a significant increase from a median of 15 (range 10–21) to 17 (12–24) mm after surgery (p < 0.001, ES = 0.94) (Table 2). Based on the above, the AP/ML ratio decreased from a median of 0.57 (0.35–1.29) to 0.52 (0.27–1.2) (p < 0.001, ES = 0.53), reflecting a change from a rounder to a more ellipsoid shape of the esophagus following surgery. The median SCAE increased significantly after surgery, from 95 (47–147) to 137 (72–286) mm2 (ES = 1.31, p < 0.001), corresponding to a median increase of 34% (–17 to 253%). The most pronounced improvement occurred in the patients with the largest volume of removed thyroid tissue (Fig. 2).
Esophageal compression variables before and after surgery in patients with benign symptomatic nodular goiter (n = 64)
The median esophageal deviation decreased moderately from 4 (0–23) to 3 (0–10) mm after surgery (p = 0.005, ES = 0.54). For structures surrounding the esophagus, the degrees of esophageal contact to the spine increased from a median of 74° (0–114°) before surgery to 78° (0–124°) after surgery (p = 0.03, ES = 0.31). An increase was also seen for the contact to the trachea, from a median of 105° (38–145°) prior to surgery to 118° (83–165°) (p < 0.001, ES = 0.67) following surgery.
Using multiple regression analyses, the preoperative volume of the thyroid and SCAE was significantly inversely correlated, with a reduction in SCAE of 0.35 mm2 for every 10% increase in goiter volume (p = 0.01). In parallel, a 10% increase in the weight of the removed thyroid tissue increased SCAE by 1% (p = 0.03), implying that patients with the largest goiters experienced the highest percent improvements in SCAE.
Observer Variation
From the Bland-Altman plots (Fig. 3) and intraobserver measurements, the ML width was (mean ± SD) 1.1 ± 1.4 mm smaller at the second measurement, corresponding to a mean measurement difference of 7.2 ± 9.3% (Fig. 3a). For esophageal deviation, the mean intraobserver agreement was 1.4 ± 1.8 mm (Fig. 3b), while the degrees of contact between the esophagus and the trachea were 6.3 ± 18.5° higher (p < 0.001) in the second measurement. The remaining parameters did not vary significantly between the first and the second measurement.
Patient Reported Outcomes
The mean goiter symptom score of (mean ± SD) 40 ± 21 points before surgery improved to 10 ± 10 points after surgery (ES = 1.5, p < 0.001) (Table 3). All 11 items of the goiter symptom scale improved after surgery. These included symptoms closely related to swallowing difficulties, such as “discomfort swallowing”, with scores reduced from a mean of 1.8 ± 1.2 to 0.3 ± 0.6 points postoperatively (ES = 1.6, p < 0.001). Similarly, the mean score for “difficulty swallowing” decreased from 1.2 ± 1.2 to 0.2 ± 0.5 points (ES = 1.1, p < 0.001) after surgery. The “globus sensation” also improved, with a large postsurgical mean decrease from 2.3 ± 1.3 to 0.7 ± 0.9 points (ES = 1.1, p < 0.001). The largest improvement was observed for “visible swelling in front of the neck” with a reduction from a mean 2.3 ± 1.3 to 0.2 ± 0.5 points (ES = 2.1, p < 0.001).
The symptom scores in patients with benign nodular goiter before and after surgery
Five patients (7.8%) reported either no improvement or worsening symptoms after surgery. The most pronounced deterioration was an increase of 5 points on the Goiter Symptom Scale in 1 of these patients, who experienced a decrease in SCAE, from 115 to 95 mm2.
Correlations between goiter volume, esophageal compression/deviation, and goiter symptoms were evaluated by multiple regression analyses. A 10% increase in SCAE was found to correlate with a 0.6-point improvement in Goiter Symptom Score (p = 0.03). However, none of the remaining parameters of esophageal anatomy were found to correlate with changes in goiter symptoms.
Discussion
This study demonstrated significant postoperative improvements in the esophageal anatomy in patients with benign nodular goiter. The ML width of the esophagus as well as the SCAE increased considerably following surgery. In addition, the esophageal deviation decreased, and the esophageal contact to the spine and the trachea increased, likely due to a widened esophagus. All but 4 patients showed an improvement in SCAE, thus reflecting that fibrotic tissue formation around the esophagus during goiter development as well as in the postoperative period is of no major concern.
The Goiter Symptom Score decreased significantly after surgery with large reductions in both globus sensation and swallowing difficulties. We have demonstrated, for the first time, that symptoms related to the esophageal function improve along with the changes in the esophageal anatomy. The correlation between changes in SCAE and goiter symptoms indicates that this parameter may be a useful marker of esophageal compression in future studies. However, SCAE alone is not sufficient for explaining the developments in goiter symptoms, as the Goiter Symptom Score improved postoperatively by 30 points on average, while SCAE accounted for a reduction of only 0.6 points in goiter symptoms per 10% increase in SCAE. Compression of other neck structures, e.g., the trachea and spine, by goiter, might also contribute significantly to the various items included in goiter symptoms [7].
Instead of thyroidectomy, patients with benign goiter may undergo radioiodine therapy [34] or laser thermal or radiofrequency ablation [35], with which side effects such as voice changes and postoperative hypothyroidism are more likely avoided [36-39]. However, the effects on the esophageal anatomy of these nonsurgical treatment options remain to be evaluated. Monitoring the impact of these treatments on the esophagus, functionally or anatomically, should be considered in future trials, the main aim being to obtain comparisons with the effects of thyroid surgery.
Hitherto, research regarding esophageal compression and deviation has been sparse and inconclusive. A study on patients with substernal goiter investigating dysphagia and esophageal compression, detected by computed tomography, did not identify any correlation, but the study was characterized by a small number of highly selected patients [24]. Other studies found positive correlations between esophageal compression and symptoms [22, 23], but definitions of esophageal compression and deviation were lacking, thereby hindering meaningful comparisons with our results. A retrospective study on 198 patients found a positive correlation (of unreported magnitude) between preoperative dysphagia and image findings, without defining what these findings represented [23]. A previous study by our group found no major association between esophageal motility disturbances and swallowing difficulties in patients with goiter [27], but that study may have been underpowered as it included only 33 patients. An alternative explanation may be that esophageal compression does not cause significant esophageal dysfunction, despite being symptomatic.
The strengths of our study include the several precautions taken to improve the validity. Measurements were performed twice to enable intraobserver analysis, blinding of the observer was done by computer randomization, and training sessions were performed to minimize the impact of a potential learning curve. In addition, the reasonable population size with a low drop-out rate, well-characterized patients, and the use of a thoroughly validated questionnaire improved the internal validity of the results. Importantly, the exact definition of the measured parameters of esophageal compression makes it feasible to compare interventional techniques in future studies.
A few limitations also need to be addressed. Due to the lack of a control group, we were not able to demonstrate whether the esophageal anatomy normalized completely after surgery. In addition, although our center receives a large number of unselected patients, the study possibly suffered from selection bias, since only 64 of 267 patients with symptomatic goiter were included. Finally, an assessment was made only at 6 months after surgery, thus excluding us from making any conclusions about the relationship between symptoms and the esophageal anatomy in the early postoperative period and in the long term.
Conclusion
Thyroidectomy leads to substantial improvements in esophageal anatomy, as assessed by MRI, and this correlates with swallowing symptoms in patients with goiter. This information is valuable when offering goiter patients guidance on which effects of surgery to expect. This information is not yet available for the nonsurgical alternatives for goiter reduction in toxic or nontoxic goiter patients.
Statement of Ethics
The study was approved by The Regional Scientific Ethics Committee for Southern Denmark (S-20130096).
Disclosure Statement
The authors have no conflicts of interest.
Funding Sources
The study was economically supported by the Fund for Advancements of Medical Sciences, the Region of Southern Denmark, and Hans Skouby’s Foundation.
Footnotes
verified
References
- 1↑
Carlé A , Krejbjerg A, Laurberg P. Epidemiology of nodular goitre. Influence of iodine intake. Best Pract Res Clin Endocrinol Metab. 2014 Aug;28(4):465–79. 1521-690X
- 2
Gharib H , Papini E, Paschke R, Duick DS, Valcavi R, Hegedüs L, et al.; AACE/AME/ETA Task Force on Thyroid Nodules. American Association of Clinical Endocrinologists, Associazione Medici Endocrinologi, and European Thyroid Association Medical guidelines for clinical practice for the diagnosis and management of thyroid nodules: executive summary of recommendations. Endocr Pract. 2010 May-Jun;16(3):468–75. 1530-891X
- 3
Brix TH , Kyvik KO, Hegedüs L. Major role of genes in the etiology of simple goiter in females: a population-based twin study. J Clin Endocrinol Metab. 1999 Sep;84(9):3071–5.0021-972X
- 4↑
Hegedüs L , Bonnema SJ, Bennedbaek FN. Management of simple nodular goiter: current status and future perspectives. Endocr Rev. 2003 Feb;24(1):102–32. 0163-769X
- 5↑
Greenblatt DY , Sippel R, Leverson G, Frydman J, Schaefer S, Chen H. Thyroid resection improves perception of swallowing function in patients with thyroid disease. World J Surg. 2009 Feb;33(2):255–60. 0364-2313
- 6↑
Cramon P , Bonnema SJ, Bjorner JB, Ekholm O, Feldt-Rasmussen U, Frendl DM, et al. Quality of life in patients with benign nontoxic goiter: impact of disease and treatment response, and comparison with the general population. Thyroid. 2015 Mar;25(3):284–91. 1050-7256
- 7↑
Sorensen JR , Lauridsen JF, Døssing H, Nguyen N, Hegedüs L, Bonnema SJ, et al. Thyroidectomy Improves Tracheal Anatomy and Airflow in Patients with Nodular Goiter: A Prospective Cohort Study. Eur Thyroid J. 2017 Nov;6(6):307–14. 2235-0640
- 8↑
Lombardi CP , Raffaelli M, De Crea C, D’Alatri L, Maccora D, Marchese MR, et al. Long-term outcome of functional post-thyroidectomy voice and swallowing symptoms. Surgery. 2009 Dec;146(6):1174–81. 0039-6060
- 9↑
Sabaretnam M , Mishra A, Chand G, Agarwal G, Agarwal A, Verma AK, et al. Assessment of swallowing function impairment in patients with benign goiters and impact of thyroidectomy: a case control study. World J Surg. 2012 Jun;36(6):1293–9. 0364-2313
- 10↑
Scerrino G , Inviati A, Di Giovanni S, Paladino NC, Di Paola V, Lo Re G, et al. Esophageal motility changes after thyroidectomy; possible associations with postoperative voice and swallowing disorders: preliminary results. Otolaryngol Head Neck Surg. 2013 Jun;148(6):926–32. 0194-5998
- 11
Sørensen JR , Hegedüs L, Kruse-Andersen S, Godballe C, Bonnema SJ. The impact of goitre and its treatment on the trachea, airflow, oesophagus and swallowing function. A systematic review. Best Pract Res Clin Endocrinol Metab. 2014 Aug;28(4):481–94. 1521-690X
- 12
Lombardi CP , Raffaelli M, D’alatri L, De Crea C, Marchese MR, Maccora D, et al. Video-assisted thyroidectomy significantly reduces the risk of early postthyroidectomy voice and swallowing symptoms. World J Surg. 2008 May;32(5):693–700. 0364-2313
- 13
Eng OS , Potdevin L, Davidov T, Lu SE, Chen C, Trooskin SZ. Does nodule size predict compressive symptoms in patients with thyroid nodules? Gland Surg. 2014 Nov;3(4):232–6.2227-684X
- 14↑
Alfonso A , Christoudias G, Amaruddin Q, Herbsman H, Gardner B. Tracheal or esophageal compression due to benign thyroid disease. Am J Surg. 1981 Sep;142(3):350–4. 0002-9610
- 15↑
Bukvic BR , Zivaljevic VR, Sipetic SB, Diklic AD, Tausanovic KM, Paunovic IR. Improvement of quality of life in patients with benign goiter after surgical treatment. Langenbecks Arch Surg. 2014 Aug;399(6):755–64. 1435-2443
- 16↑
Sorensen JR , Watt T, Cramon P, Døssing H, Hegedüs L, Bonnema SJ, et al. Quality of life after thyroidectomy in patients with nontoxic nodular goiter: A prospective cohort study. Head Neck. 2017 Nov;39(11):2232–40. 1043-3074
- 17
Tae K , Kim KY, Yun BR, Ji YB, Park CW, Kim DS, et al. Functional voice and swallowing outcomes after robotic thyroidectomy by a gasless unilateral axillo-breast approach: comparison with open thyroidectomy. Surg Endosc. 2012 Jul;26(7):1871–7. 0930-2794
- 18↑
Maung KH , Hayworth D, Nix PA, Atkin SL, England RJ. Thyroidectomy does not cause globus pattern symptoms. J Laryngol Otol. 2005 Dec;119(12):973–5. 0022-2151
- 19↑
Sorensen JR , Markoew S, Dossing H, Hegedus L, Bonnema SJ, Godballe C. Changes in Swallowing Symptoms and Esophageal Motility After Thyroid Surgery: A Prospective Cohort Study. World J Surg. 2017.0364-2313
- 20
Glinoer D , Verelst J, Ham HR. Abnormalities of esophageal transit in patients with sporadic nontoxic goitre. Eur J Nucl Med. 1987;13(5):239–43. 0340-6997
- 21↑
Jørgensen F , Hesse B, Grønbaek P, Fogh J, Haunsø S. Abnormal oesophageal function in patients with non-toxic goiter or enlarged left atrium, demonstrated by radionuclide transit measurements. Scand J Gastroenterol. 1989 Dec;24(10):1186–92. 0036-5521
- 22↑
Netterville JL , Coleman SC, Smith JC, Smith MM, Day TA, Burkey BB. Management of substernal goiter. Laryngoscope. 1998 Nov;108(11 Pt 1):1611–7. 0023-852X
- 23↑
Shin JJ , Grillo HC, Mathisen D, Katlic MR, Zurakowski D, Kamani D, et al. The surgical management of goiter: part I. Preoperative evaluation. Laryngoscope. 2011 Jan;121(1):60–7. 0023-852X
- 24↑
Mackle T , Meaney J, Timon C. Tracheoesophageal compression associated with substernal goitre. Correlation of symptoms with cross-sectional imaging findings. J Laryngol Otol. 2007 Apr;121(4):358–61. 0022-2151
- 25↑
Sorensen JR , Johansen J, Gano L, Sørensen JA, Larsen SR, Andersen PB, et al. A “package solution” fast track program can reduce the diagnostic waiting time in head and neck cancer. Eur Arch Otorhinolaryngol. 2014 May;271(5):1163–70. 0937-4477
- 26↑
Pustelnik FS , Gronbek C, Døssing H, Nguyen N, Bonnema SJ, Hegedüs L, et al. The compensatory enlargement of the remaining thyroid lobe following hemithyroidectomy is small and without impact on symptom relief. Eur Arch Otorhinolaryngol. 2018 Jan;275(1):161–7. 0937-4477
- 27↑
Sorensen JR . The impact of surgery on quality of life, esophageal motility, and tracheal anatomy and airflow in patients with benign nodular goiter. Dan Med J. 2018 Apr;65(4):65.2245-1919
- 28↑
Watt T , Barbesino G, Bjorner JB, Bonnema SJ, Bukvic B, Drummond R, et al. Cross-cultural validity of the thyroid-specific quality-of-life patient-reported outcome measure, ThyPRO. Qual Life Res. 2015 Mar;24(3):769–80. 0962-9343
- 29
Watt T , Groenvold M, Deng N, Gandek B, Feldt-Rasmussen U, Rasmussen AK, et al. Confirmatory factor analysis of the thyroid-related quality of life questionnaire ThyPRO. Health Qual Life Outcomes. 2014 Sep;12(1):126. 1477-7525
- 30
Wong CK , Lang BH, Lam CL. A systematic review of quality of thyroid-specific health-related quality-of-life instruments recommends ThyPRO for patients with benign thyroid diseases. J Clin Epidemiol. 2016 Oct;78:63–72. 0895-4356
- 31↑
Watt T , Cramon P, Hegedüs L, Bjorner JB, Bonnema SJ, Rasmussen AK, et al. The thyroid-related quality of life measure ThyPRO has good responsiveness and ability to detect relevant treatment effects. J Clin Endocrinol Metab. 2014 Oct;99(10):3708–17. 0021-972X
- 32↑
Watt T , Hegedüs L, Groenvold M, Bjorner JB, Rasmussen AK, Bonnema SJ, et al. Validity and reliability of the novel thyroid-specific quality of life questionnaire, ThyPRO. Eur J Endocrinol. 2010 Jan;162(1):161–7. 0804-4643
- 33↑
Chapter 2. In: Cohen J. Statistical Power Analyses for Be- havioral Sciences. Hillsdale: Lawrence Erlbaum; 1988.
- 34↑
Bonnema SJ , Hegedüs L. Radioiodine therapy in benign thyroid diseases: effects, side effects, and factors affecting therapeutic outcome. Endocr Rev. 2012 Dec;33(6):920–80. 0163-769X
- 35↑
Ha EJ , Baek JH, Kim KW, Pyo J, Lee JH, Baek SH, et al. Comparative efficacy of radiofrequency and laser ablation for the treatment of benign thyroid nodules: systematic review including traditional pooling and bayesian network meta-analysis. J Clin Endocrinol Metab. 2015 May;100(5):1903–11. 0021-972X
- 36↑
Chung SR , Suh CH, Baek JH, Park HS, Choi YJ, Lee JH. Safety of radiofrequency ablation of benign thyroid nodules and recurrent thyroid cancers: a systematic review and meta-analysis. Int J Hyperthermia. 2017 Dec;33(8):920–30.1464-5157
- 37
Gharib H , Hegedüs L, Pacella CM, Baek JH, Papini E. Clinical review: Nonsurgical, image-guided, minimally invasive therapy for thyroid nodules. J Clin Endocrinol Metab. 2013 Oct;98(10):3949–57. 0021-972X
- 38
Døssing H , Bennedbæk FN, Hegedüs L. Interstitial laser photocoagulation (ILP) of benign cystic thyroid nodules—a prospective randomized trial. J Clin Endocrinol Metab. 2013 Jul;98(7):E1213–7. 0021-972X
Footnotes
This study is registered at the Danish Data Protection Agency and www.clinicaltrials.gov (NCT03072654).